Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | RAB9A | P51151 | 2/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.31 |
| ▸ | POLB | P06746 | 2/20 | 0.30 |
| ▸ | NPC1 | O15118 | 1/20 | 0.30 |
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24824834 | 0.80 | NOS2 (0.33) | L3MBTL1GAARAB9ASMN1; SMN2POLB | |
| SCHEMBL23200412 | 0.80 | NOS2 (0.33) | L3MBTL1GAARAB9ASMN1; SMN2POLB | |
| SCHEMBL10424345 | 0.69 | NOS2 (0.30) | — | |
| SCHEMBL14738505 | 0.67 | — | — | |
| SCHEMBL14739011 | 0.67 | — | — | |
| SCHEMBL14738884 | 0.67 | — | — | |
| SCHEMBL23041676 | 0.67 | — | — | |
| SCHEMBL2882789 | 0.67 | — | — | |
| SCHEMBL22915204 | 0.67 | — | — | |
| SCHEMBL1188560 | 0.66 | HPGD (0.38) | L3MBTL1GAARAB9ASMN1; SMN2POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230399318-A1 | RENEWABLE OILS: COMPOSITION, PROCESS OF MAKING AND FORMULATION | RiKarbon, Inc (US) | 2023-12-14 | — | — | US | disclosed |
| US-20230399318-A1 | RENEWABLE OILS: COMPOSITION, PROCESS OF MAKING AND FORMULATION | RiKarbon, Inc (US) | 2023-12-14 | — | — | US | disclosed |
| WO-2022093748-A1 | RENEWABLE OILS: COMPOSITION, PROCESS OF MAKING AND FORMULATION | RIKARBON, INC. (US) | 2022-05-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230399318-A1 | RENEWABLE OILS: COMPOSITION, PROCESS OF MAKING AND FORMULATION | CBR1, CBR3, AKR1C3 | L3MBTL1 2911/4885GAA 4163/4885RAB9A 3570/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.